Comparison of Postdischarge Outcomes Between Valve-in-Valve Transcatheter Mitral Valve Replacement and Reoperative Surgical Mitral Valve Replacement

Keyphrases

• 180-day Mortality 9%
• 90-day Mortality 9%
• Adult Patients 9%
• Bioprosthetic Mitral Valve 18%
• Complete Heart Block 9%
• Confidence Interval 27%
• Discharge Home 9%
• Discharge Outcomes 100%
• Discharge Time 9%
• Hospital Stay 9%
• Length of Stay 9%
• Longitudinal Data 9%
• Major Bleeding 9%
• Major Morbidity 18%
• Median Difference 9%
• Mitral Valve Repair 100%
• Nationwide Readmissions Database 9%
• New Onset 9%
• No Significant Difference 9%
• Odds Ratio 18%
• Overlap Weights 18%
• Pacemaker Placement 9%
• Permanent Pacemaker 9%
• Postoperative Outcomes 9%
• Propensity Score Weighting 9%
• Randomized Controlled Trial 9%
• Readmission 18%
• Renal Failure 9%
• Reoperative 100%
• Replacement Approach 9%
• Risk-adjusted 9%
• Total Hospital Costs 9%
• Transapical 9%
• Transapical Approach 9%
• Transcatheter Mitral Valve Repair (TMVr) 100%
• Transeptal 18%
• Treatment Group 9%
• Valve-in-valve 100%

Medicine and Dentistry

• Apoplexy 7%
• Hospital Cost 7%
• Major Bleeding 7%
• Mitral Valve 15%
• Mitral Valve Replacement 100%
• Odds Ratio 15%
• Permanent Pacemaker 7%
• Randomized Controlled Trial 7%
• Renal Failure 7%
• Third-Degree Atrioventricular Block 7%
• Treatment Group 7%